Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

DLL4 anticorps

DLL4 Reactivité: Humain FACS Hôte: Souris Monoclonal MHD4-46 unconjugated
N° du produit ABIN2749211
  • Antigène Voir toutes DLL4 Anticorps
    DLL4 (delta-Like 4 (DLL4))
    Reactivité
    • 49
    • 37
    • 15
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 55
    • 14
    • 8
    • 3
    • 1
    Souris
    Clonalité
    • 57
    • 24
    Monoclonal
    Conjugué
    • 45
    • 8
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp DLL4 est non-conjugé
    Application
    • 40
    • 28
    • 13
    • 13
    • 11
    • 10
    • 8
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    Flow Cytometry (FACS)
    Specificité
    The mouse monoclonal antibody MHD4-46 recognizes the extracellular domain of DLL4 (Delta-like ligand 4), a type I transmembrane protein which plays an important role in vascular development.
    Réactivité croisée (Details)
    Human
    Purification
    Purified by protein-A affinity chromatography.
    Pureté
    > 95 % (by SDS-PAGE)
    Immunogène
    recombinant soluble human DLL4
    Clone
    MHD4-46
    Isotype
    IgG1 kappa
    Top Product
    Discover our top product DLL4 Anticorps primaire
  • Indications d'application
    Flow cytometry: Recommended dilution: 1-4 μg/mL
    Restrictions
    For Research Use only
  • Concentration
    1 mg/mL
    Buffer
    Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C
    Stockage commentaire
    Store at 2-8°C. Do not freeze.
  • Sekine, Koyanagi, Koyama, Hozumi, Chiba, Yagita: "Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes." dans: Arthritis research & therapy, Vol. 14, Issue 2, pp. R45, (2012) (PubMed).

    Oishi, Sunamura, Egawa, Motoi, Unno, Furukawa, Habib, Yagita: "Blockade of delta-like ligand 4 signaling inhibits both growth and angiogenesis of pancreatic cancer." dans: Pancreas, Vol. 39, Issue 6, pp. 897-903, (2010) (PubMed).

    Yamanda, Ebihara, Asada, Okazaki, Niu, Ebihara, Koyanagi, Yamaguchi, Yagita, Arai: "Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade." dans: Blood, Vol. 113, Issue 15, pp. 3631-9, (2009) (PubMed).

  • Antigène
    DLL4 (delta-Like 4 (DLL4))
    Autre désignation
    DLL4 (DLL4 Produits)
    Synonymes
    anticorps hdelta2, anticorps Delta4, anticorps si:ch211-244p18.5, anticorps zgc:136596, anticorps delta like canonical Notch ligand 4, anticorps delta-like 4 (Drosophila), anticorps DLL4, anticorps Dll4, anticorps dll4
    Sujet
    Delta like canonical Notch ligand 4,DLL4 (Delta-like 4) is one of five ligands of Notch receptors. It interacts with Notch1 and Notch4. DLL4 is up-regulated at sites of physiologic and pathologic angiogenesis, whereas its expression is low in most adult normal tissues. It is also highly expressed in human clear-cell renal carcinomas, bladder cancers, and breast cancers. Blocking the DLL4-Notch interaction seems to be a promissing therapeutic approach.,Delta like ligand 4, AOS6, canonical Notch ligand 4
    ID gène
    54567
    UniProt
    Q9NR61
    Pathways
    Signalisation Notch
Vous êtes ici:
Support technique